A Study of XY0206 Tablets in Patients With Relapsed / Refractory Acute Myeloid Leukemia

Clinical trial NCT04471064 · UNKNOWN

Trial details

NCT number: NCT04471064
Sponsor: Shijiazhuang Yiling Pharmaceutical Co. Ltd
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2020-09-15
Primary completion: 2024-02-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.